Segall Bryant & Hamill’s Veradigm Inc. Common Stock MDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-238,301
Closed -$2.94M 872
2018
Q1
$2.94M Sell
238,301
-27,453
-10% -$390K 0.07% 264
2017
Q4
$3.87M Sell
265,754
-61,909
-19% -$860K 0.09% 232
2017
Q3
$4.66M Sell
327,663
-37,598
-10% -$486K 0.11% 205
2017
Q2
$4.66M Sell
365,261
-1,560
-0.4% -$18.9K 0.11% 203
2017
Q1
$4.65M Sell
366,821
-55,794
-13% -$662K 0.11% 188
2016
Q4
$4.32M Sell
422,615
-14,695
-3% -$168K 0.11% 192
2016
Q3
$5.76M Sell
437,310
-3,250
-0.7% -$43.5K 0.15% 145
2016
Q2
$5.59M Sell
440,560
-318,840
-42% -$4.23M 0.15% 155
2016
Q1
$10M Sell
759,400
-178,220
-19% -$2.34M 0.25% 116
2015
Q4
$14.4M Sell
937,620
-29,885
-3% -$429K 0.35% 85
2015
Q3
$12M Buy
967,505
+262,650
+37% +$3.62M 0.29% 104
2015
Q2
$9.64M Buy
+704,855
New +$9.52M 0.22% 140

Other funds holding MDRX

Segall Bryant & Hamill's MDRX Position: Q2 2018 in Review

Segall Bryant & Hamill sold out of Veradigm Inc. Common Stock (MDRX) in Q2 2018, closing a stake of 238,301 shares — an estimated $2.94M sold.

Segall Bryant & Hamill first reported a position in MDRX in Q2 2015 and held it in 12 quarters. The position peaked at $14.4M in Q4 2015. 253 funds tracked by Wall St. Rank hold MDRX as of Q2 2018.

  • Segall Bryant & Hamill reported no remaining Veradigm Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • Segall Bryant & Hamill sold 238,301 Veradigm Inc. Common Stock shares in Q2 2018, an estimated $2.94M.
  • Segall Bryant & Hamill first reported a position in Veradigm Inc. Common Stock in Q2 2015 and held it in 12 quarters.
  • Segall Bryant & Hamill's Veradigm Inc. Common Stock position peaked at $14.4M in Q4 2015.
  • 253 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q2 2018.

Based on Segall Bryant & Hamill's 13F filing for Q2 2018, filed 8 Aug 2018.